Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
novonorm 0,5 mg tabletten
novo nordisk pharma ag - repaglinidum - tabletten - repaglinidum 0.5 mg, poloxamerum 188, povidonum k 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas pro compresso. - orales antidiabetikum - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
novonorm 1,0 mg tabletten
novo nordisk pharma ag - repaglinidum - tabletten - repaglinidum 1 mg, poloxamerum 188, povidonum k 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas, e 172 (flavum) pro compresso. - orales antidiabetikum - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
novonorm 2,0 mg tabletten
novo nordisk pharma ag - repaglinidum - tabletten - repaglinidum 2 mg, poloxamerum 188, povidonum k 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas, e 172 (rubrum) pro compresso. - orales antidiabetikum - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
repaglinide rivopharm 0.5 mg compresse
rivopharm sa - repaglinidum - compresse - repaglinidum 0.5 mg, polacrilinum kalicum, megluminum, cellulosum microcristallinum, maydis amylum, povidonum k 90, glycerolum, poloxamerum, calcii hydrogenophosphas, magnesii stearas, pro compresso. - antidiabetico - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
repaglinide rivopharm 1 mg compresse
rivopharm sa - repaglinidum - compresse - repaglinidum 1 mg, polacrilinum kalicum, megluminum, cellulosum microcristallinum, maydis amylum, povidonum k 90, glycerolum, poloxamerum, calcii hydrogenophosphas, magnesii stearas, e 172 (flavum), pro compresso. - antidiabetico - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
repaglinide rivopharm 2 mg compresse
rivopharm sa - repaglinidum - compresse - repaglinidum 2 mg, polacrilinum kalicum, megluminum, cellulosum microcristallinum, maydis amylum, povidonum k 90, glycerolum, poloxamerum, calcii hydrogenophosphas, magnesii stearas, e 172 (rubrum), pro compresso. - antidiabetico - synthetika
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fentanyl pharmabide 50 mikrogramm/stunde transdermales pflaster
pharmabide ltd (8122369) - fentanyl - transdermales pflaster - teil 1 - transdermales pflaster; fentanyl (06903) 5,5 milligramm
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fentanyl pharmabide 100 mikrogramm/stunde transdermales pflaster
pharmabide ltd (8122369) - fentanyl - transdermales pflaster - teil 1 - transdermales pflaster; fentanyl (06903) 11 milligramm
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fentanyl pharmabide 75 mikrogramm/stunde transdermales pflaster
pharmabide ltd (8122369) - fentanyl - transdermales pflaster - teil 1 - transdermales pflaster; fentanyl (06903) 8,25 milligramm
Deutschland -
Deutsch -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fentanyl pharmabide 25 mikrogramm/stunde transdermales pflaster
pharmabide ltd (8122369) - fentanyl - transdermales pflaster - teil 1 - transdermales pflaster; fentanyl (06903) 2,75 milligramm